Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · IEX Real-Time Price · USD
34.09
+0.35 (1.04%)
Mar 28, 2024, 3:59 PM EDT - Market closed

Supernus Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2009
Revenue
607.52667.24579.78520.4392.76408.9302.24215147.4792.68
Upgrade
Revenue Growth (YoY)
-8.95%15.09%11.41%32.50%-3.95%35.29%40.57%45.80%59.12%671.10%
Upgrade
Cost of Revenue
83.7887.2275.0652.4616.6615.3615.2211.998.425.76
Upgrade
Gross Profit
523.74580.02504.71467.94376.1393.54287.02203.02139.0486.92
Upgrade
Selling, General & Admin
336.36377.22304.76200.68153.25154.7137.91106.0189.0672.61
Upgrade
Research & Development
91.5974.5590.4775.9669.189.2149.5842.7929.1419.59
Upgrade
Other Operating Expenses
102.5782.6329.9917.65.185.190000
Upgrade
Operating Expenses
530.53534.4425.22294.24227.52249.1187.48148.8118.292.2
Upgrade
Operating Income
-6.7945.6179.5173.7148.57144.4499.5454.2220.84-5.28
Upgrade
Interest Expense / Income
2.427.0723.4223.7522.7118.111.575.094.775.62
Upgrade
Other Expense / Income
-11.97-22.2-17.1-18.7-21.62-13.84-2.65-1.241.46-0.6
Upgrade
Pretax Income
2.7760.7473.18168.65147.49140.18100.6250.3714.61-10.3
Upgrade
Income Tax
1.450.0319.7541.734.4329.1843.33-40.850.670.63
Upgrade
Net Income
1.3260.7153.42126.95113.06110.9957.2891.2213.94-10.93
Upgrade
Net Income Growth
-97.83%13.64%-57.92%12.29%1.86%93.76%-37.20%554.20%--
Upgrade
Shares Outstanding (Basic)
55545353525251494742
Upgrade
Shares Outstanding (Diluted)
56625454545453525142
Upgrade
Shares Change
-10.01%13.47%1.24%-0.24%-0.52%1.50%3.08%1.07%21.06%32.69%
Upgrade
EPS (Basic)
0.021.131.012.412.162.131.131.840.29-0.26
Upgrade
EPS (Diluted)
0.021.040.982.362.102.051.081.760.28-0.26
Upgrade
EPS Growth
-98.08%6.12%-58.47%12.38%2.44%89.81%-38.64%528.57%--
Upgrade
Free Cash Flow
110.53116.41125.08134.71141.74128.14112.6165.2132.42-25.09
Upgrade
Free Cash Flow Per Share
2.032.172.362.562.702.462.221.320.68-0.59
Upgrade
Gross Margin
86.21%86.93%87.05%89.92%95.76%96.24%94.97%94.43%94.29%93.79%
Upgrade
Operating Margin
-1.12%6.84%13.71%33.38%37.83%35.33%32.93%25.22%14.13%-5.69%
Upgrade
Profit Margin
0.22%9.10%9.21%24.39%28.79%27.14%18.95%42.43%9.46%-11.79%
Upgrade
Free Cash Flow Margin
18.19%17.45%21.57%25.89%36.09%31.34%37.26%30.33%21.98%-27.07%
Upgrade
Effective Tax Rate
52.47%0.05%26.99%24.72%23.35%20.82%43.07%-81.11%4.56%-
Upgrade
EBITDA
90.04153.36129.19210.54176.85165.35110.3257.8620.3-3.75
Upgrade
EBITDA Margin
14.82%22.98%22.28%40.46%45.03%40.44%36.50%26.91%13.77%-4.04%
Upgrade
Depreciation & Amortization
84.8685.5432.618.146.667.068.132.40.920.93
Upgrade
EBIT
5.1867.8196.6192.4170.19158.29102.1955.4619.38-4.67
Upgrade
EBIT Margin
0.85%10.16%16.66%36.97%43.33%38.71%33.81%25.79%13.14%-5.04%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).